Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Reports Steep Increase in Revenues, Earnings for Q1

NEW YORK, April 28 (GenomeWeb News) - Third Wave Technologies reported a steep increase in revenues and earnings for the first quarter today.

 

Revenues were $15.3 million, up from $8.5 million during the first quarter last year. This was higher than expected, Third Wave said, due to increased demand for genomic research products in Japan, where the government's fiscal year ended at the end of March.

 

Research and development costs for the quarter stayed flat, at $2.9 million.

 

Earnings for the quarter were $2.8 million, or $.07 per share, compared to a loss of $2.9 million, or $.07 per share, during the year-ago period.

 

As of March 31, Third Wave had $59.9 million in cash, cash equivalents, and short-term investments.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.